Format
Sort by
Items per page

Send to

Choose Destination

Links from Nucleotide

Items: 1 to 20 of 552

1.

Architecture of the human interactome defines protein communities and disease networks.

Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, Colby G, Gebreab F, Gygi MP, Parzen H, Szpyt J, Tam S, Zarraga G, Pontano-Vaites L, Swarup S, White AE, Schweppe DK, Rad R, Erickson BK, Obar RA, Guruharsha KG, Li K, Artavanis-Tsakonas S, Gygi SP, Harper JW.

Nature. 2017 May 25;545(7655):505-509. doi: 10.1038/nature22366. Epub 2017 May 17.

2.

[Genetic polymorphisms of KIR2DS4 gene among ethnic Hans from southern China].

Zhen J, Zhang G, Yu Q, He L, Xu Y, Zou H, Deng Z.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017 Feb 10;34(1):21-25. doi: 10.3760/cma.j.issn.1003-9406.2017.01.005. Chinese.

PMID:
28186587
3.

The impact of KIR2DS4 gene on clinical outcome after hematopoietic stem cell transplantation.

Burek Kamenaric M, Stingl Jankovic K, Grubic Z, Serventi Seiwerth R, Maskalan M, Nemet D, Mikulic M, Zunec R.

Hum Immunol. 2017 Feb;78(2):95-102. doi: 10.1016/j.humimm.2016.11.010. Epub 2016 Dec 18.

PMID:
27998801
4.

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.

Isitman G, Tremblay-McLean A, Lisovsky I, Bruneau J, Lebouché B, Routy JP, Bernard NF.

PLoS One. 2016 Oct 12;11(10):e0164517. doi: 10.1371/journal.pone.0164517. eCollection 2016.

5.

Evaluation of KIR3DL1/KIR3DS1 polymorphism in Behçet's disease.

Erer B, Takeuchi M, Ustek D, Tugal-Tutkun I, Seyahi E, Özyazgan Y, Duymaz-Tozkir J, Gül A, Kastner DL, Remmers EF, Ombrello MJ.

Genes Immun. 2016 Dec;17(7):396-399. doi: 10.1038/gene.2016.36. Epub 2016 Oct 6.

PMID:
27708262
6.

[Cloning and sequencing of KIR2DL1 framework gene cDNA and identification of a novel allele].

Sun G, Wang C, Zhen J, Zhang G, Xu Y, Deng Z.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Oct;33(5):694-7. doi: 10.3760/cma.j.issn.1003-9406.2016.05.026. Chinese.

PMID:
27577226
7.

The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection.

Lisovsky I, Isitman G, Tremblay-McLean A, Song R, DaFonseca S, Lebouchẻ B, Routy JP, Bruneau J, Bernard NF.

Clin Exp Immunol. 2016 Dec;186(3):336-346. doi: 10.1111/cei.12849. Epub 2016 Sep 9.

PMID:
27506421
8.

A multifaceted computational report on the variants effect on KIR2DL3 and IFNL3 candidate gene in HCV clearance.

Singh P, Dass JF.

Mol Biol Rep. 2016 Oct;43(10):1101-17. doi: 10.1007/s11033-016-4044-5. Epub 2016 Jul 26.

PMID:
27461217
9.

KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles.

Bari R, Thapa R, Bao J, Li Y, Zheng J, Leung W.

Sci Rep. 2016 Mar 31;6:23689. doi: 10.1038/srep23689.

10.

Possible Role of HLA-G, LILRB1 and KIR2DL4 Gene Polymorphisms in Spontaneous Miscarriage.

Nowak I, Malinowski A, Barcz E, Wilczyński JR, Wagner M, Majorczyk E, Motak-Pochrzęst H, Banasik M, Kuśnierczyk P.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(6):505-514. Epub 2016 Mar 14.

11.

Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis.

Song S, Miranda CJ, Braun L, Meyer K, Frakes AE, Ferraiuolo L, Likhite S, Bevan AK, Foust KD, McConnell MJ, Walker CM, Kaspar BK.

Nat Med. 2016 Apr;22(4):397-403. doi: 10.1038/nm.4052. Epub 2016 Feb 29.

12.

The early onset of type 1 autoimmune hepatitis has a strong genetic influence: role of HLA and KIR genes.

Podhorzer A, Paladino N, Cuarterolo ML, Fainboim HA, Paz S, Theiler G, Capucchio M, López SI, Machicote A, Montal S, Podesta G, Fainboim L.

Genes Immun. 2016 Apr;17(3):187-92. doi: 10.1038/gene.2016.7. Epub 2016 Feb 18.

PMID:
26890333
13.

The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans.

Hollenbach JA, Pando MJ, Caillier SJ, Gourraud PA, Oksenberg JR.

Genes Immun. 2016 Apr;17(3):199-202. doi: 10.1038/gene.2016.5. Epub 2016 Feb 11.

14.

Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.

Ridley A, Hatano H, Wong-Baeza I, Shaw J, Matthews KK, Al-Mossawi H, Ladell K, Price DA, Bowness P, Kollnberger S.

Arthritis Rheumatol. 2016 Apr;68(4):901-14. doi: 10.1002/art.39515.

15.

KIR2DL4 expression rather than its single nucleotide polymorphisms correlates with pre-eclampsia.

Wang D, Tian Y, Zhao Y, Liu L, Liu X, Wu F.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14535-41. eCollection 2015.

16.

Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.

Gooneratne SL, Center RJ, Kent SJ, Parsons MS.

Clin Exp Immunol. 2016 Apr;184(1):101-9. doi: 10.1111/cei.12752. Epub 2016 Feb 4.

17.

Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease.

Díaz-Peña R, Vidal-Castiñeira JR, Moro-García MA, Alonso-Arias R, Castro-Santos P.

Hum Immunol. 2016 Jan;77(1):104-9. doi: 10.1016/j.humimm.2015.10.020. Epub 2015 Nov 2.

PMID:
26542067
18.

Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).

Osman AE, Eltayeb-ELSheikh N, Mubasher M, Al Harthi H, Alharbi S, Hamza MA, ElGhazali G.

Hum Immunol. 2016 Jan;77(1):110-4. doi: 10.1016/j.humimm.2015.10.019. Epub 2015 Nov 2.

PMID:
26542066
19.

KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy.

Yeung DT, Tang C, Vidovic L, White DL, Branford S, Hughes TP, Yong AS.

Blood. 2015 Dec 17;126(25):2720-3. doi: 10.1182/blood-2015-07-655589. Epub 2015 Oct 23.

20.

KIR2DS4 and Its Variant KIR1D Are Associated with Acute Graft-versus-Host Disease, Cytomegalovirus, and Overall Survival after Sibling-Related HLA-Matched Transplantation in Patients with Donors with KIR Gene Haplotype A.

Wu X, Yao Y, Bao X, Zhou H, Tang X, Han Y, Ma X, Liu Y, Chen J, Zhou H, Jing S, Gu B, Xu Y, Sun A, He J, Wu D.

Biol Blood Marrow Transplant. 2016 Feb;22(2):220-5. doi: 10.1016/j.bbmt.2015.10.004. Epub 2015 Oct 22.

Supplemental Content

Support Center